Completed
LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy
NCT04562922
- Conditions
- Adverse Event, Agranulocytosis, Cytopenia, +5 more
- Locations
-
Not specified